Leprolomin | CAS#68984-67-8 | bioactive chemical

MedKoo Cat#: 559018 | Name: Leprolomin

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Leprolomin is a bioactive chemical.

Chemical Structure

Leprolomin

CAS#68984-67-8

Theoretical Analysis

MedKoo Cat#: 559018

Name: Leprolomin

CAS#: 68984-67-8

Chemical Formula: C20H22O8

Exact Mass: 390.1315

Molecular Weight: 390.38

Elemental Analysis: C, 61.53; H, 5.68; O, 32.79

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Leprolomin;

IUPAC/Chemical Name

1-(6-(3-acetyl-2,6-dihydroxy-4-methoxy-5-methylphenoxy)-2-hydroxy-4-methoxy-3-methylphenyl)ethan-1-one

InChi Key

QNCHFYWKVGDPCD-UHFFFAOYSA-N

InChi Code

InChI=1S/C20H22O8/c1-8-12(26-5)7-13(14(10(3)21)16(8)23)28-20-17(24)9(2)19(27-6)15(11(4)22)18(20)25/h7,23-25H,1-6H3

SMILES Code

CC(C1=C(OC2=C(O)C(C)=C(OC)C(C(C)=O)=C2O)C=C(OC)C(C)=C1O)=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 390.38 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Kar HK, Sharma AK, Misra RS, Zaheer SA, Mukherjee A, Mukherjee R, Beena KR, Kaur H, Nair SK, Talwar GP. Induction of lepromin positivity by a candidate anti-leprosy vaccine Mycobacterium w in lepromin negative healthy contacts of multibacillary leprosy patients. Indian J Lepr. 1992 Oct-Dec;64(4):495-500. PubMed PMID: 1308525. 2: Dharmendra, Loew J. The immunological skin tests in leprosy. Part II. The isolated protein antigen in relation to the classical Matsuda reaction and the early reaction to lepromin. 1942. Indian J Med Res. 2012 Sep;136(3):9p following 502. PubMed PMID: 23210150. 3: Chaudhuri S, Fotedar A, Talwar GP. Lepromin conversion in repeatedly lepromin negative BL/LL patients after immunization with autoclaved Mycobacterium w. Int J Lepr Other Mycobact Dis. 1983 Jun;51(2):159-68. PubMed PMID: 6684642. 4: Sharma P, Kar HK, Kaur H, Misra RS, Mukherjee A, Mukherjee R, Rani R. Induction of lepromin positivity and immunoprophylaxis in household contacts of multibacillary leprosy patients: a pilot study with a candidate vaccine, Mycobacterium w. Int J Lepr Other Mycobact Dis. 2000 Jun;68(2):136-42. PubMed PMID: 11036493. 5: Hajra SK, Chaudhury S, Ghosh S, Kundu S. Lepromin conversion after repeated lepromin administration. Indian J Dermatol. 1981 Jan;26(1):24-6. PubMed PMID: 7347316. 6: Cestari TF, Kripke ML, Baptista PL, Bakos L, Bucana CD. Ultraviolet radiation decreases the granulomatous response to lepromin in humans. J Invest Dermatol. 1995 Jul;105(1):8-13. PubMed PMID: 7615981. 7: Job CK, Sanchez RM, Hastings RC. Effect of repeated lepromin testing on experimental nine-banded armadillo leprosy. Indian J Lepr. 1985 Oct-Dec;57(4):716-27. PubMed PMID: 3915005. 8: Job CK, Kirchheimer WF, Sanchez RM. Tissue response to lepromin, an index of susceptibility of the armadillo to M. leprae infection--a preliminary report. Int J Lepr Other Mycobact Dis. 1982 Jun;50(2):177-82. PubMed PMID: 6749706. 9: Hanks JH, Nakayama T, Abe M, Tuma M, Bechelli LM, Martínez Domínguez V. Studies towards the standardization of lepromin. Progress and prospects. Bull World Health Organ. 1970;42(5):703-9. PubMed PMID: 5311057; PubMed Central PMCID: PMC2427501. 10: Baskin GB, Gormus BJ, Martin LN, Wolf RH, Watson EA, Walsh GP, Meyers WM, Binford CH. The lepromin test in rhesus monkeys. Int J Lepr Other Mycobact Dis. 1986 Sep;54(3):427-36. PubMed PMID: 3746044. 11: CONVIT J, RASSI E. Lepromin and tuberculin tests in Venezuelan leprosy foci; induction of lepromin reactivity by BCG vaccination. Int J Lepr. 1954 Jul-Sep;22(3):303-10. PubMed PMID: 13232779. 12: Karazawa EH, Proença NG, Mimica I, Kliemann TA, Martinez EW, Guedes M, Farias LR. [Comparative study of the intradermal reaction performed with whole lepromin and ultrasonic-treated lepromin in normal subjects]. Hansenol Int. 1980 Dec;5(2):123-8. Portuguese. PubMed PMID: 7341485. 13: Sengupta U. Studies on lepromin and soluble antigens of M.leprae: their classification standardization and use. Indian J Lepr. 1991 Jul-Dec;63(3-4):457-65. Review. PubMed PMID: 1804898. 14: Foss NT, Pagnano PM, Bechelli LM, Simoes AL. Lymphocyte blastogenesis and lepromin reactivity in leprosy patients and their parents. Acta Leprol. 1990;7(2):119-28. PubMed PMID: 2220296. 15: Walter J. The post-lepromin scar and its significance in the control of HD. Indian J Lepr. 1989 Jul;61(3):379-86. PubMed PMID: 2527921. 16: Pagnano PM, Bechelli LM, de Lima Filho EC. [The lymphocyte transformation test using phytohemagglutinin, lepromin and M. leprae in lepromin-negative and positive leprosy: prognostic value compared with that of lepromin]. Acta Leprol. 1982 Jan-Jun;(86-87):83-95. French. PubMed PMID: 6816002. 17: Sengupta U. Experience and lessons from the use of lepromin and Mycobacterium leprae-specific serology. Lepr Rev. 2000 Dec;71 Suppl:S63-6. Review. PubMed PMID: 11201890. 18: Sharma P, Kar HK, Misra RS, Mukherjee A, Kaur H, Mukherjee R, Rani R. Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: report on a hospital-based clinical trial with the candidate antileprosy vaccine. Int J Lepr Other Mycobact Dis. 1999 Sep;67(3):259-69. PubMed PMID: 10575405. 19: Mitra DK, Joshi B, Dinda AK, Rai AK, Girdhar BK, Katoch K, Bindra MS, Sengupta U. Induction of lepromin reactivity in cured lepromatous leprosy patients: impaired chemokine response dissociates protective immunity from delayed type hypersensitivity. Microbes Infect. 2009 Dec;11(14-15):1122-30. doi: 10.1016/j.micinf.2009.08.006. Epub 2009 Aug 22. PubMed PMID: 19703581. 20: Haddad N, Bechelli LM, Kwapinski JB, Simão ET. Double blind trial on the effect of certain soluble cytoplasmic mycobacterial antigens on the late reactivity to lepromin. Int J Lepr Other Mycobact Dis. 1982 Sep;50(3):325-9. PubMed PMID: 6890537.